CymitQuimica logo
Apoptosis

Apoptosis

Los inhibidores de la apoptosis son compuestos que previenen o retrasan el proceso de muerte celular programada, conocido como apoptosis. Estos inhibidores son vitales para estudiar los mecanismos de supervivencia celular y se utilizan para investigar enfermedades donde la apoptosis está desregulada, como el cáncer, los trastornos neurodegenerativos y las enfermedades autoinmunes. Al modular la apoptosis, estos inhibidores pueden ayudar en el desarrollo de terapias dirigidas a controlar la muerte celular. En CymitQuimica, ofrecemos una amplia selección de inhibidores de la apoptosis de alta calidad para apoyar su investigación en biología celular, oncología y campos relacionados.

Subcategorías de "Apoptosis"

Mostrar 6 subcategorías más

Se han encontrado 5903 productos de "Apoptosis"

Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
productos por página.
  • CHMFL-48
    Targetmol
    + Info

    CHMFL-48

    CAS:
    <p>CHMFL-48, an orally active inhibitor of BCR-ABL kinase, demonstrates efficacy against both the wild-type (wt) and various imatinib-resistant mutants. It exhibits potent inhibitory activity, with IC 50 values of 1 nM for the ABL wild-type and 0.8 nM for the ABL T315I mutant. CHMFL-48 operates by inhibiting the autophosphorylation of both wild-type and mutant BCR-ABL, affecting downstream signaling mediators including STAT5 and CRKL. This disruption leads to cell cycle arrest and triggers apoptosis. Given its properties, CHMFL-48 is a promising candidate for research on chronic myeloid leukemia (CML).</p>
    Fórmula:C31H30F3N7O
    Forma y color:Solid
    Peso molecular:573.61

    Ref: TM-T89947

    10mg
    Descatalogado
    50mg
    Descatalogado
    Producto descatalogado
  • SMIP34
    Targetmol
    + Info

    SMIP34

    CAS:
    <p>SMIP34 is an inhibitor of PELP1 that demonstrates the capability to reduce cell viability and colony formation. Additionally, SMIP34 induces cell apoptosis (apoptosis) and causes cell cycle arrest in the S phase. It reduces the expression of PELP1 and exhibits anti-tumor activity. SMIP34 also has potential for research in triple-negative breast cancer (TNBC).</p>
    Fórmula:C20H15ClFN5O2S
    Forma y color:Liquid
    Peso molecular:443.88

    Ref: TM-T89834

    10mg
    Descatalogado
    50mg
    Descatalogado
    Producto descatalogado
  • DETD-35
    Targetmol
    + Info

    DETD-35

    CAS:
    <p>DETD-35 is a promising chemical compound in anti-melanoma therapy, functioning as an inhibitor of the MEK-ERK, Akt, and STAT3 signaling pathways. It enhances cancer cell apoptosis (Apoptosis) and diminishes resistance to Vemurafenib in cancer cells. The compound exhibits IC 50 values of 2.7, 6.0, 3.9, 3.1, and 2.5 μM against melanoma cell lines B16-F10, MeWo, SK-MEL-2, A2058c, and A375c, respectively. DETD-35 offers significant potential for advancing research in melanoma treatment strategies.</p>
    Fórmula:C27H24O6
    Forma y color:Solid
    Peso molecular:444.48

    Ref: TM-T89997

    10mg
    Descatalogado
    50mg
    Descatalogado
    Producto descatalogado